期刊文献+

甲氧明对心肺转流冠状动脉搭桥后老年低血压患者冠脉血流的影响 被引量:14

Effects of methoxamine on coronary artery blood flow in elderly patients with post volume treatment hypotension after cardiopulmonary bypass undergoing coronary artery bypass grafting
下载PDF
导出
摘要 目的探讨静脉泵注甲氧明和去氧肾上腺素对老年冠状动脉搭桥术患者心肺转流停机经容量治疗后仍低血压的疗效及对冠脉血流的影响。方法择期行冠状动脉搭桥心肺转流停机经容量治疗后低血压(MAP低于基础血压的70%)的老年患者40例,男27例,女13例,年龄>65岁,ASAⅡ或Ⅲ级,随机分为甲氧明组(M组)和去氧肾上腺素组(P组),每组20例。患者出现低血压后开始静脉泵药,M组起始速度为3μg·kg^(-1)·min^(-1),P组起始速度为0.24μg·kg^(-1)·min^(-1),根据患者血压调整泵药速度,单次递增、递减速度均为起始的1/3,使MAP波动幅度不超过基础值的20%。分别在泵药前、泵药后3、5、10、15、30 min经食管超声心动图(TEE)测量冠脉窦收缩期血流速度时间积分(SVTI)和舒张期血流速度时间积分(DVTI),并计算冠脉窦血流量(CSBF)。结果 P组1例患者因未能获得理想TEE切面而退出研究。与泵药前比较,泵药后不同时点M组和P组SVTI、DVTI、CSBF明显升高(P<0.01)。与P组比较,泵药后5、10、15、30min M组DVTI和CSBF明显升高(P<0.05或P<0.01)。M组术后发生心房颤动2例,频发室性早搏1例;P组术后发生心动过缓1例,频发室性早搏1例。结论静脉泵注甲氧明和去氧肾上腺素均可纠正老年冠状动脉搭桥患者心肺转流后低血压状态,但甲氧明增加冠脉血流量更明显,可能对冠心病患者更有利。 Ojective To investigate the effects of intravenous infusion of methoxamine and phenylephrine on blood pressure and coronary artery blood flow in elderly patients with post volume treatment hypotension after cardiopulmonary bypass (CPB) undergoing coronary artery bypass grafting (CABG). Methods Forty patients, physical status ASA Ⅱ or Ⅲ, 〉65 years old, undergoing CABG, following CPB, with a mean arterial pressure (MAP) 〈70% of baseline, despite adequate volume replacement (based on achieving a normal CVP), were randomly assigned to methoxamine group (group M, n=20) or phenylephrine group (group P, n=20). The initial infusion rate was 3 μg·kg-1·min-1 in group M and 0.24 μg·kg-1·min-1in group P, respectively. The rate was increased or decreased by one third of initial dose in order to maintain the MAP at the target level (±20% of baseline MAP). Coronary sinus (CS), systolic blood flow velocity time integral (SVTI), diastolic velocity time integral (DVTI), CS blood flow (CSBF) were recorded before administration, at 3, 5, 10, 15, 30 min after administration. Results Compared with pre-administration, SVTI, DVTI, CSBF were increased at each point in the two groups (P〈0.05 or P〈0.01). SVI was increased at 15 min and 30 min in group M (P〈0.05). Compared with group P, DVTI and CSBF at 10, 15 min and 30 min was higher in group M (P〈0.05 or P〈0.01). There were 2 cases of atrial fibrillation and 1 case of frequent ventricular premature beat after operation in group M; 1 case of bradycardia and 1 case of frequent ventricular premature beats after operation in group P. Conclusion Intravenous infusion of methoxamine and phenylephrine both can correct post volume treatment hypotension after CPB in elderly patients undergoing CABG, but methoxamine increases coronary blood flow more significantly and may be more beneficial to patients with coronary heart disease.
作者 卜心怡 王亭亭 葛亚力 魏海燕 施韬 苏中宏 史宏伟 BU Xinyi;WANG Tingting;GE Yali;WEI Haiyan;Sill Tao;SHU Zhonghong;Sill Hongwei .(Department of Anes- thesiology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China)
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2018年第5期436-440,共5页 Journal of Clinical Anesthesiology
关键词 冠状动脉搭桥术 低血压 甲氧明 去氧上腺素 心肺转流 Coronary artery bypass Hypotensiom Methoxamine Phenylephrine Cardioplumonary bypass
  • 相关文献

参考文献3

二级参考文献28

  • 1刘增波,谭跃萍,方平,宋维,吴淑彬,丛阳.经胸多普勒超声心动图对正常冠状静脉窦的测定及其可重复性的研究[J].中国医学影像技术,2005,21(12):1888-1890. 被引量:8
  • 2方平,谭跃萍,刘增波,蔡丽萍,吴淑彬,丛阳.采用超声心动图探测冠状静脉窦评价运动员心肌灌注[J].中国运动医学杂志,2006,25(4):435-438. 被引量:8
  • 3Tayarna E, Ueda T, Shojima T, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovase Thorac Surg, 2007, 6: 715-719.
  • 4Pappalardo F, Landoni G, Franco A, et al. Prolonged refractory hypotension in cardiac surgery after institution of car diopulmonary bypass. J Cardiothorac Vasc Anesth, 2002, 16: 477-479.
  • 5Suoiaranta-Ylinen RT, Vento AE, IDa tila T, et al Vasopressin, when added to norepinephrlne, was not associated with increased predicted mortality after cardiac surgery. Scand J Surg, 2007, 96: 314-318.
  • 6Dunser MW, Mayr AJ, Ulmer H, et al. The effects of vasopressin on systemic hemodynamies in catecholamine-resistant seplic and postcardiotomy shock: a retrospective analysis. Anesth Analg, 2001, 93: 7-13.
  • 7Dunser MW, Mayr AJ, Stallinger A, et al. Cardiac performance during vasopressin infusion in posteardiotomy shock. Intensive Care Med, 2002, 28: 746-751.
  • 8Morales DL, Gregg D, Helman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg, 2000, 69: 102-106.
  • 9Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation, 2003, 107: 2313-2319.
  • 10Russell JA. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care, 2007, 13: 383-391.

共引文献26

同被引文献117

引证文献14

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部